Sangamo Biosciences reported $0 in Stock for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Alnylam Pharmaceuticals ALNY:US $ 88.98M 10.46M
Amgen AMGN:US $ 4554M 143M
Bayer BAYN:GR € 11371M 502M
Biocryst Pharmaceuticals BCRX:US $ 23.38M 7.23M
Biogen BIIB:US $ 1294.2M 78.8M
Biomarin Pharmaceutical BMRN:US $ 802.32M 15.96M
Gilead Sciences GILD:US $ 2587M 88M
GlaxoSmithKline GSK:LN 4664M 1339M
IONIS PHARMACEUT IONS:US $ 19.81M 4.22M
Karyopharm Therapeutics KPTI:US $ 3.47M 404K
Novartis NOVN:VX SF 6880M 117M
Sarepta Therapeutics SRPT:US $ 208.1M 9.1M
Ultragenyx Pharmaceutical RARE:US $ 21.08M 3.27M
Vertex Pharmaceuticals VRTX:US $ 367.7M 28.8M